Advances in bioavailability. Innovations in delivery technologies and dose forms. Proven results from our team of scientists, researchers, and regulatory experts.
Whatever your challenge, we have an expert who can solve it.
This on-demand webinar will identify ways to determine the ideal formulation for your molecule
Catalent Schordorf has expanded controlled release and hot melt extrusion capabilities
Bioconjugates show great promise to improve existing therapeutics.
Learn more about the challenge of continuous supply available to meet clinical study needs,
Commercial success of a drug can be influenced by patient’s perception of the formulation.
Catalent worked with the client to bring a vastly superior sublingual product to market.
Creation of a custom packaging/distribution concept to meet the client’s needs.
Creation of a custom packaging and distribution solution to meet this client’s unique needs.
Identification of the impurities combined with analytical and sample handling challenges.
Case study describing custom batch manufacture of the product at a reasonable cost.
Catalent's OptiGel Bio™ technology can provide a pathway for an IV to oral delivery conversion.
Patient compliance with medication can be especially challenging for pediatric populations.
Extractable and leachable detection methods and best practices.
The first-ever survey investigating patient experiences with clinical trial materials
A detailed understanding of the material science of the tablet structure
Innovative biotechnology company exploring therapeutics for neuroscience indications
How Clinical Supply Management Systems can bring efficiencies to support Project Lifecycle
Selection of the optimal solid form is a critical decision in the development lifecycle.
Global manufacturers are exploring the possibility of producing biosimilars
This presentation discusses the description of a media fill matrix approach, including: bracketing, use of FMEA (Failure Mode Effects Analysis) in determination of worst case media fill conditions, tracking and frequency, along with the introduction of randomized media fills.
Bracketing, FMEA , tracking, frequency, along with the introduction of randomized media fills.
Bracketing, use of FMEA in determination of worst case media fill conditions, tracking and frequency, along with the introduction of randomized media fills.
In today's enviroment solution providers are preferred over CMO's.
This presentation discusses challenges when considering LBDDS.
Specialized analytical and formulation tools aid in successful, timely Development of LBDDS.
Key considerations for selection, benefits, limitations, and future prospects.
Bend Research and Catalent enter into an agreement to provide integrated solutions.
This webcast will highlight the latest omega-3 drug developments.
Catalent expert Mike Jenkins explains the change Catalent's facility is making.
Explore and learn about advances in lipid-based drug delivery systems (LBDDS).
Catalent expert interviewed at INTERPHEX 2011 about the blow/fill/seal process.
A comparison between GPEx® and traditional cell line engineering technology.
This case study describes the development and optimization of a two-day bioassay, capable of accurately assessing potency of a therapeutic molecule in terms of an end-point cell survival response
Catalent’s scientific expertise and integrated method development and validation services provided the successful launching of the Phase 1 clinical trial of multiple antisense oligonucleotides.
Catalent was challenged to create solutions that would reduce shipment costs; optimize site inventory; develop a lightweight, increased payload; and design reusable materials to lower the client’s overall costs.
This case study describes the qPCR method for detection and quantification of residual E.coli genomic DNA contamination of therapeutic moieties and active pharmacological products.
This article looks into current problems in assuring virological safety of biopharmaceuticals.
Catalent expert, Mike Merges, explores practical considerations for bioassays.
Project management is becoming more important as companies increase outsourcing.
Explore overcoming challenges in the tech transfer of biopharma products.
Catalent expert discusses how Catalent is becoming a one-stop shop for global customers.
Removal of impurities is critical in the purification process for production of final products.
Integrating quality by design into sterile manufacturing facilities is becoming more important.
This presentation focuses on improving oral delivery for poorly soluble/permeable drugs.
Hot melt extrusion is being explored as a way to overcome solubility challenges.
Explore the issues with technical transfer in regardss to complex pharmaceutical products
Explore the continuing role of NMR Spectroscopy in characterization of specialty polymers
Investigate the relationship between poorly-soluble drugs and disintegration time of (ODTs)
Evaluate the pharmacokinetic behavior of nanosized fenofibrate administered orally
Disintegration and dissolution characteristics of novel, polysaccharidebased shell softgels
Determination of elemental impurities in support of USP <232> and <233>
Development of digestion methods for determination of elemental impurities
Development and validation of a method for determination of bismuth
From formulation to specialty packaging, this article explores patient adherence.
Explore fit-for-purpose strategies in discovery and development of solid-state forms.
A guideline for selecting the best methods to analyze and characterize antibodies.
An introduction to regulatory documents surrounding leachables and extractables.
Examine the current market, industry trends, and discuss the latest technologies.
Address principles and practices of stability studies in the drug development
Unlocking the therapeutic potential of BCS Type II & IV compounds
Regulatory and global trade requirements for shipment into key clinical trial markets.
Learn steps taken to improve timelines and throughput in generation of mammalian cell lines
An overview of stability studies during drug product lifecycles.
Zydis fast-dissolve formulation for Zelapar (Selegiline anti-Parkinson’s compound) had a positive impact on therapeutic profile vs. Selegiline in traditional tablets.
VP of Corporate Strategy and Development discusses emerging drug-delivery technologies.
This presentation deals with the challenges of using suppliers from around the globe
Catalent executive discusses excellence in compliance in Pharmaceutical Formulation & Quality
As the use of “universal” HPLC detectors and charged aerosol detectors become more common
Focuses on new innovation drug delivery devices for patient-administered therapies
Catelent CEO John Chiminski discusses our offerings
New study shows superior patient compliance with oral fast dissolve delivery
Exploration of the largest trends in the prefilled syringe and autoinjection devices
‘Lean’ is a familiar term in European manufacturing since markets are more competitive
New strategies in formulation development are helping overcome molecule challenges
Softgel Technology as a Lipid-Based Delivery Tool for Bioavailability Enhancement
The aseptic blow-fill-seal (B/F/S) systems have experienced growth.
Case Study: Marchesini Group for Catalent Pharma Solutions: Efficient Syringe Packaging
Catalent experts talk about the increasing demand of prefilled syringes
Presentation detailing inhaled products as well as emerging technologies in this area
Clinical trials are a critical step in the approval process for new drugs.
Selection of a solid-state form is an important decision in development of small molecule API's
VP of business development discusses blow/fill/seal market and offerings
Fish gelatin support of nanoparticle formation of poorly water-solubles during wet milling
The striking efficiency gains Catalent has achieved with the Lean System for Managing
Modern healthcare challenges and predictions for pharmaceutical market growth
General review of Catalent’s new technology that optimizes API and profitability
Effect of a Kollicoat Top-coat on the physical stability of enteric-coated softgels
Study on the impact of emulsion liposomal liquid and lyophilized liposomal formulations.
Why oral disintegrating tablets are so important to the industry’s oral dose form kit
How manufacturers can partner with contract packagers in new and increasingly complex ways
Explore a cGMP manufacturing model for reducing operating costs and speeding up drugs to market
Pros and cons of options, plus discussion of global problems and lack of foreign security
Laser diffraction particle size analysis – a robust and efficient alternative
Development procedures to reduce antibody effect on Protein Z, with validation results
Study shows import plasticizer level, & potential for migration from coating to shell
Determination of residual solvents in API by headspace GC-MS needs multiple analyses
Implications of FDA release and responsive technologies available to the manufacturer
How to make the decision to outsource, navigate vendor selection, and monitor results
VP of global sales overviews drug delivery technologies and services as well as key trends
The more efficient a bioassay method transfer, the faster to regulatory submission
Why companies are looking for partners, how the process works, and looking out for a CRO
2009 European study why choosing softgels can impact lifecycle management and marketing
Approach to validate from preclinical development to final commercial implementation
Rapid development model for formulation feasibility & accelerated stability evaluation
Method to separate un-derivatized protein Z (uTPZ) from derivatized TPZ in 3 species
Validate responsive ELISA for the detection of IPZ in monkey, rat, and human serum fluid
Robust options available for micro-dosing inhalation powders with some important caveats
Study investigates design using synthetic molecule recognizing immunoglobulin in serums
Novel approach to validate a method for the determination of water content
New shell and hot-filling that are highly viscous or semi-solid at room temperature
Proven, acceptable NMR spectroscopy test for common EMAs in raw materials and APIs